Publications by authors named "Benard Combe"

Claim this Profile
S
Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: week 52 results from SPIRIT-P2.
Mark C Genovese, Benard Combe, Joel M Kremer, Tsen-Fang Tsai, Frank Behrens

Rheumatology (Oxford)· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial.
Peter Nash, Bruce Kirkham, Masato Okada, Proton Rahman, Benard Combe

Lancet· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis